World-renowned skilled to guide pediatric cardiology division at Washington College Faculty of Drugs

Andrew C. Glatz, MD, an internationally acknowledged skilled in pediatric interventional cardiology, has been chosen to guide the Division of Pediatric Cardiology within the Division of Pediatrics at Washington College Faculty of Drugs in St. Louis.

He additionally will change into the Louis Larrick Ward Professor of Pediatrics and deal with sufferers at St. Louis Kids’s Hospital. His appointment will start in March.

Glatz is an affiliate professor of pediatrics on the College of Pennsylvania Perelman Faculty of Drugs and the founding medical director of the Cardiac Heart Medical Analysis Core at Kids’s Hospital of Philadelphia (CHOP), the place he’s additionally a pediatric interventional heart specialist. He additionally serves as one in every of three website principal investigators for CHOP’s participation within the Pediatric Coronary heart Community, a analysis consortium funded by the Nationwide Coronary heart, Lung, and Blood Institute (NHLBI) of the Nationwide Institutes of Well being (NIH).

We’re delighted that Dr. Glatz might be taking over this function at Washington College Faculty of Drugs. He brings a wealth of investigative, administrative, academic and scientific expertise to this place. He earned his medical diploma from Washington College, and it’s a pleasure to welcome him and his household again to St. Louis.”

Gary A. Silverman, MD, PhD, the Harriet B. Spoehrer Professor, head of the Division of Pediatrics, and pediatrician-in-chief at St. Louis Kids’s Hospital

Glatz has experience in treating sufferers with single ventricle coronary heart illness who want advanced neonatal interventions. His follow is also broadly centered on interventional cardiology, and diagnosing and treating congenital coronary heart illness in a wide range of sufferers, from newborns to adults. His work contains high quality enchancment efforts that embody initiatives to cut back radiation publicity within the catheterization laboratory in addition to the chance of blood clots which will happen throughout interventional procedures.

Glatz is also a school member within the Heart for Pediatric Medical Effectiveness and serves as affiliate chief for analysis within the Division of Cardiology. He’s the assistant program director for the Pediatric Cardiology Analysis Coaching Program and co-chair of the scholarship oversight committees within the Division of Cardiology.

His analysis is funded by grants from the NHBLI, American Coronary heart Affiliation, American School of Cardiology, Kids’s Coronary heart Basis, CHD Coalition, and Large Hearts to Little Hearts. He’s additionally a website principal investigator and member of the management group of the “Security of ApiXaban On Pediatric Coronary heart illness On the preventioN of Embolism” (SAXOPHONE) examine, a global, multicenter randomized trial evaluating apixaban to the usual of care for youngsters with congenital coronary heart illness requiring long-term anticoagulation remedy to forestall blood clots. He’s additionally a co-chair for the “COmparison of Strategies of Pulmonary blood circulate Augmentation in neonates: Shunt versus Stent” (COMPASS) trial, a multicenter randomized trial supported by the NIH/NHLBI’s Pediatric Coronary heart Community, evaluating ductal stenting to surgical shunting for newborns with a situation referred to as ductal-dependent pulmonary blood circulate. As well as, he’s a founding member and scientific chair for the Congenital Cardiac Analysis Collaborative.

Glatz earned a bachelor’s diploma in psychology from Princeton College in 1996 and his medical diploma at Washington College Faculty of Drugs in 2002. He accomplished his internship and residency in pediatrics at Kids’s Hospital of Philadelphia after which continued his coaching with fellowships in pediatric cardiology and interventional pediatric cardiology, additionally at CHOP. Later, he earned a grasp’s diploma in scientific epidemiology from the College of Pennsylvania Perelman Faculty of Drugs.

Glatz will take over for David T. Balzer, MD, and Janet Scheel, MD, professors of pediatrics who led the division as interim co-directors.


Washington College Faculty of Drugs

#Worldrenowned #skilled #lead #pediatric #cardiology #division #Washington #College #Faculty #Drugs